The Asahi Kasei Healthcare Materials Division offers microcrystalline
cellulose (MCC) for oral solid dosage forms of
pharmaceuticals and nutraceuticals; and hyaluronic acid nanogel for drug delivery system (DDS)
material mainly for
injection formulations of pharmaceuticals.
A noteworthy advantage of our products is their ability to facilitate challenging and/or
innovative formulations of
pharmaceuticals and nutraceuticals that customers are bringing to market.
Products category
Asahi Kasei is a diversified Japanese chemical company with over a century of
history.
We operate in the three business sectors of Material, Homes, and Health Care.
The commitment of the Asahi Kasei Group:
To do all that we can in every era to help the people of the world make the most of life
and attain fulfillment in living.
Since our founding, we have always been deeply committed to contributing to the
development of society, boldly anticipating the emergence of new needs.
This is what we mean by “Creating for Tomorrow.”
Nobeoka, Miyazaki, Japan, cradle of Asahi Kasei
CPHI Frankfurt 2025
Date : October 28-30, 2025
Location : Messe Frankfurt, Germany
Product category : Microcrystalline cellulose (MCC)
Our booth : #8.0Q7
Supply Side Global 2025
Date : October 27-30, 2025
Location : Mandalay Bay, Las Vegas, USA
Product category : Microcrystalline cellulose (MCC)
Our booth : #7425
AAPS 2025 PharmSci 360
Date : November 9-12, 2025
Location : Henry B. Gonzalez Convention Center, San Antonio, USA
Product category : Microcrystalline cellulose (MCC)
Our booth : #3443